Management of stage IV rectal cancer: palliative options
- PMID: 21412493
- PMCID: PMC3051134
- DOI: 10.3748/wjg.v17.i7.835
Management of stage IV rectal cancer: palliative options
Abstract
Approximately 30% of patients with rectal cancer present with metastatic disease. Many of these patients have symptoms of bleeding or obstruction. Several treatment options are available to deal with the various complications that may afflict these patients. Endorectal stenting, laser ablation, and operative resection are a few of the options available to the patient with a malignant large bowel obstruction. A thorough understanding of treatment options will ensure the patient is offered the most effective therapy with the least amount of associated morbidity. In this review, we describe various options for palliation of symptoms in patients with metastatic rectal cancer. Additionally, we briefly discuss treatment for asymptomatic patients with metastatic disease.
Keywords: Endorectal stenting; Laser ablation; Malignant bleeding; Malignant obstruction; Palliative therapy; Rectal cancer.
Figures

Similar articles
-
Palliation of malignant rectal obstruction from invasive prostate cancer with multiple overlapping self-expanding metal stents.South Med J. 2009 Dec;102(12):1257-9. doi: 10.1097/SMJ.0b013e3181bf69a4. South Med J. 2009. PMID: 20016435
-
Indications and results of endoscopic rectal stenting.J Gastrointest Surg. 2004 Mar-Apr;8(3):266-9. doi: 10.1016/j.gassur.2003.11.018. J Gastrointest Surg. 2004. PMID: 15019920
-
Palliative management for patients with subacute obstruction and stage IV unresectable rectosigmoid cancer: colostomy versus endoscopic stenting: final results of a prospective randomized trial.Am J Surg. 2012 Sep;204(3):321-6. doi: 10.1016/j.amjsurg.2011.11.013. Epub 2012 May 9. Am J Surg. 2012. PMID: 22575396 Clinical Trial.
-
Endoscopic palliation of colorectal cancer.Hematol Oncol Clin North Am. 2002 Aug;16(4):1015-29. doi: 10.1016/s0889-8588(02)00034-5. Hematol Oncol Clin North Am. 2002. PMID: 12418060 Review.
-
Expandable metal stents for malignant colorectal strictures.Gastrointest Endosc Clin N Am. 2011 Jul;21(3):511-33, ix. doi: 10.1016/j.giec.2011.04.005. Epub 2011 May 14. Gastrointest Endosc Clin N Am. 2011. PMID: 21684468 Review.
Cited by
-
Modified simultaneous integrated boost radiotherapy for an unresectable huge refractory pelvic tumor diagnosed as a rectal adenocarcinoma.World J Gastroenterol. 2014 Dec 28;20(48):18480-6. doi: 10.3748/wjg.v20.i48.18480. World J Gastroenterol. 2014. PMID: 25561820 Free PMC article.
-
ACO/ARO/AIO-22 - External beam radiotherapy combined with endorectal high-dose-rate brachytherapy in elderly and frail patients with rectal cancer: A prospective multicentre trial of the German Rectal Cancer Study Group.Clin Transl Radiat Oncol. 2025 Apr 13;53:100958. doi: 10.1016/j.ctro.2025.100958. eCollection 2025 Jul. Clin Transl Radiat Oncol. 2025. PMID: 40276115 Free PMC article.
-
The small molecule NLRP3 inhibitor RRx-001 potentiates regorafenib activity and attenuates regorafenib-induced toxicity in mice bearing human colorectal cancer xenografts.Am J Cancer Res. 2022 Apr 15;12(4):1912-1918. eCollection 2022. Am J Cancer Res. 2022. PMID: 35530283 Free PMC article.
-
Efficacy of ex vivo activated and expanded natural killer cells and T lymphocytes for colorectal cancer patients.Biomed Rep. 2014 Jul;2(4):505-508. doi: 10.3892/br.2014.264. Epub 2014 Mar 26. Biomed Rep. 2014. PMID: 24944796 Free PMC article.
-
Near-Infrared Fluorescent Endoscopic Image-Guided Photothermal Ablation Therapy of Colorectal Cancer Using Dual-Modal Gold Nanorods Targeting Tumor-Infiltrating Innate Immune Cells in a Transgenic TS4 CRE/APC loxΔ468 Mouse Model.ACS Appl Mater Interfaces. 2019 Jun 19;11(24):21353-21359. doi: 10.1021/acsami.9b04186. Epub 2019 Jun 4. ACS Appl Mater Interfaces. 2019. PMID: 31117445 Free PMC article.
References
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–249. - PubMed
-
- Rothenberger DA. Palliative therapy of rectal cancer. Overview: epidemiology, indications, goals, extent, and nature of work-up. J Gastrointest Surg. 2004;8:259–261. - PubMed
-
- Van Cutsem E, Oliveira J. Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20 Suppl 4:61–63. - PubMed
-
- Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, et al. NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw. 2009;7:838–881. - PubMed
-
- Miner TJ, Jaques DP, Tavaf-Motamen H, Shriver CD. Decision making on surgical palliation based on patient outcome data. Am J Surg. 1999;177:150–154. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical